MET and gastric cancer: Notably, amplifications in RICTOR (p = 0.0328), MYC (p = 0.0049), CDK6 (p = 0.0377), and MET (p = 0.0145) were significantly more frequent in the PD‐L1 high (CPS ≥5) GC patient cohort.